Table 1.
Demographic and Clinical Characteristics of the Sample
| Male (n=216) |
Female (n=78) |
Transgender (n=23) |
|
|---|---|---|---|
| Age (years) | |||
| Mean ± SD | 45.1 ± 8.3 | 45.9 ± 8.2 | 43.3 ± 9.1 |
| Range | 22–77 | 26–66 | 27–60 |
| Race | |||
| White/Caucasian | 50% | 23% | 13% |
| Black/African American | 28% | 61% | 61% |
| Hispanic/Latino | 11% | 8% | 13% |
| More than one race | 8% | 4% | 9% |
| Other | 3% | 4% | 4% |
| Education | |||
| High school/GED or less | 37% | 60% | 65% |
| Some college/trade school | 38% | 26% | 22% |
| Completed college | 25% | 14% | 13% |
| Employment | |||
| Medical leave/disability | 72% | 81% | 83% |
| Employed/student | 18% | 10% | 13% |
| Not employed | 10% | 9% | 4% |
| Household income (monthly) | |||
| <$1000 | 66% | 77% | 74% |
| $1,000-$1999 | 22% | 20% | 26% |
| ≥$2,000 | 12% | 3% | 0% |
| In a relationship | 31% | 47% | 26% |
| Have children | 23% | 81% | 4% |
| Time since HIV diagnosis | |||
| Mean ± SD (yrs) | 12.4 ± 7.0 | 11.1 ± 6.5 | 11.5 ± 7.4 |
| Range (yrs) | 0.2 – 25.0 | 0.2 – 27.0 | 1.0 – 26.0 |
| AIDS diagnosis | 56% | 46% | 35% |
| On anti-retroviral (ART) therapy | 74% | 63% | 65% |
| CD4 (cells/mm3) | |||
| Mean ± SD | 462 ± 275 | 439 ± 246 | 380 ± 232 |
| Range | 4 – 1740 | 4 – 950 | 7 – 864 |
| % <200 | 16% | 17% | 26% |
| % <500 | 59% | 61% | 70% |
| Viral load (copies/mL) | |||
| % with detectable VL | 47% | 51% | 73% |
| Mean of detectable VL ± SD | 37,905 ± 84,824 | 68,954 ± 153,712 | 14,651 ± 23,163 |
| Range of detectable VL | 63 – 500,000 | 91 – 500,000 | 50 – 80,428 |